The NCI Transition Career Development Award (K22)
The NCI Transition Career Development Award (K22) supports mentored, non-independent investigators ready to transition to independent academic faculty positions.
For more complete information, reference Program Announcements PAR-21-111 (K22 Independent Clinical Trial Required), PAR-21-128 (K22 Independent Clinical Trial Not Allowed), and PAR-21-318 (K22 Independent Basic Experimental Studies with Humans Required) and/or contact the program staff.
The objective of the NCI Transition Career Development Award (K22) is to provide support to mentored, non-independent investigators in transitioning to their first independent tenure-track faculty cancer research positions, or their equivalent. It is expected that the Research Plan be based on the candidate’s original project ideas and/or hypotheses. The K22 project can be within the overall scope of the postdoctoral mentor’s research awards. However, there should be no text duplication or duplication of the scientific aims, and the candidate’s application should propose a scientific research question or approach that is distinct from the mentor’s pending or active research grants.
NCI will not support both a K22 award and an active or pending research grant that propose substantially the same research.
At the time of the award, the candidate must be:
Citizenship or green card is not needed to apply. Citizenship or green card is needed at the time of award issuance.
|Foreign Nationals with Student Visas||Not eligible for this award|
Clinical or research fellows working in all areas of cancer research ready to transition to independent academic tenure-track assistant faculty positions.
|Effort Level/ Commitment||Candidate must commit a minimum of 9 person months (75%) full-time professional effort to the K22 Career Development Award.|
|Duration of Award||3 years; the K22 Award is not renewable|
|Salary||Up to $100K/year + fringe benefits|
|Research Development Support: Salaries for Technical Support, Consultant Costs, Equipment, Supplies, Travel, and Statistical Support||Up to $50K/year|
|F&A Costs/Indirect Costs||8%|
|Ancillary Personnel Support: Salary for Mentors, Secretarial and Administrative Assistance, etc.||Not allowed|
How to Apply
- Applications must be submitted electronically.
- Applicants must follow the instructions in the SF424(R&R) Application Guide, as well as any program-specific instructions noted in Section IV. of the Program Announcement.
- When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions in Program Announcement.
- Applications that do not comply with these instructions may be delayed or not be accepted for review.
Application Receipt Dates and Review Schedule
|Receipt Cycle||Receipt Date: New Application||Receipt Date: Resubmission Application||Initial Review||Council Review||Earliest Possible Start Date*|
|1||February 12||March 12||June/July||September/October||December|
|2||June 12||July 12||October/November||January/February||April|
|3||October 12||November 12||February/March||May/June||July|
* Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Applications are due by 5 pm local time.
When a standard submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Review and Selection Process
The Center for Scientific Review (CSR) and the National Cancer Institute (NCI) review applications for completeness and for conformance to all eligibility requirements and special provisions and requirements. Incomplete applications will be returned to the applicant without further consideration.
ZCA1 RTRB-R(02) Special Emphasis Panel convened by the Division of Extramural Activities of the NCI, evaluates applications according to the review criteria listed in the Program Announcement. Before an award is made, the National Cancer Advisory Board (NCAB) conducts a second level of review and ensures that an application meets the broad program needs and priorities of the NCI and the National Cancer Program.
For review criteria for the K22 grant mechanism, see Section V. Application Review Information of the Program Announcement.
- Program Announcement PAR-21-111 (K22 Independent Clinical Trial Required)
- Program Announcement PAR-21-128 (K22 Independent Clinical Trial Not Allowed)
- Program Announcement PAR-21-318 (K22 Independent Basic Experimental Studies with Humans Required)
- Current List of K22 Awards
- ZCA1 RTRB-R(02) Special Emphasis Panel
- Training Funding Opportunities to Promote Diversity
- Overview of the Grant Process
- NCI Resources for Researchers
- NIH Grants Policy Statement (GPS)- see section 12
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the K22 Award, contact:
- Dr. Sonia B. Jakowlew
- Dr. Michael Schmidt
- Phone: 240-276-5630
For information regarding fiscal and/or budget issues, contact:Grant Management Contact:
- Amy Bartosch
For information regarding review issues, contact:
- Referral Officer
Division of Extramural Activities